Your Cholesterol Number Isn't the Problem — Here's What Actually Is
Hello, beautiful soul.
If you've ever sat in a doctor's office and been handed a statin prescription because your cholesterol was "too high," you're not alone. Millions of people receive that prescription every single year. And if you walked out of that appointment feeling a little unsettled — like the explanation didn't quite add up — your instincts were telling you something worth listening to.
Here's what I want you to know: cholesterol is not your enemy.
I've spent years studying this through the lens of terrain medicine, and what I keep coming back to is this — elevated cholesterol is never a random nor a malfunction. It's your body doing exactly what it was designed to do. And when we understand what it's actually responding to, we stop seeing it as a number to suppress and start seeing it as a message to investigate.
The story we were told
For more than five decades, cardiovascular medicine has operated on the premise that elevated cholesterol drives heart disease — and that statins, by lowering cholesterol, protect the heart. This framework has made statins among the most prescribed medications in the world.
What's less often discussed is how that framework was built. The foundational research came from a study that selected data from seven countries out of twenty-two — and when all twenty-two are included, the relationship between cholesterol and cardiovascular mortality largely disappears. The "normal" cholesterol threshold has been systematically lowered over the decades, with each revision expanding statin eligibility by millions of patients. The 2001 guidelines alone increased statin eligibility by 140% in a single update. And at multiple points along the way, the majority of panel members writing those guidelines had documented financial ties to statin manufacturers.
This isn't fringe thinking. These conflicts were reported in peer-reviewed journals, Time magazine, and mainstream news outlets. I'm not sharing this to scare you or to create distrust. I'm sharing it because understanding this history helps you ask better questions — for yourself.
What cholesterol is actually doing
Here's the reframe that changes everything.
Cholesterol is not a toxin. It is a foundational molecule that every cell in your body depends on. Your steroid hormones — cortisol, estrogen, progesterone, testosterone, DHEA — are all built from cholesterol. Your brain, which is roughly 25% cholesterol by dry weight, depends on it for myelin production, membrane integrity, and neurological function. Your vitamin D pathway begins with cholesterol. And your liver requires cholesterol to produce bile, which is how you digest dietary fat and absorb fat-soluble vitamins A, D, E, and K.
Now here's the part I find fascinating. When blood vessel walls sustain injury — from chronic inflammation, from elevated blood sugar, from oxidative stress — your body sends cholesterol to the site to assist in the repair. Think of it like a first responder. The cholesterol showing up in a damaged vessel isn't the cause of the problem. It's part of the response. Suppressing it with a statin doesn't repair the underlying damage. It removes the repair crew while the fire continues to burn.
What actually drives cardiovascular disease
In terrain medicine, we look upstream. And what we find, consistently, is that the true drivers of cardiovascular events are:
Chronic systemic inflammation. Measured by markers like hsCRP, homocysteine, and fibrinogen — not by LDL. Inflammation damages the vessel wall lining and initiates the cascade that leads to plaque.
Insulin resistance. Elevated fasting insulin shifts LDL toward the small, dense particle pattern that's genuinely atherogenic. It raises triglycerides, lowers HDL, and drives endothelial dysfunction. And here's a painful irony: the low-fat dietary guidelines introduced in the 1970s — designed to lower cholesterol and prevent heart disease — replaced fat with refined carbohydrates. That dietary shift dramatically accelerated the insulin resistance epidemic we're living with today.
Thyroid dysfunction. This is one of the most missed connections in conventional medicine. Thyroid hormone directly regulates the LDL receptors on your liver cells. When thyroid function is reduced — even subclinically — LDL clearance slows and serum cholesterol rises. This is basic endocrinology. And yet patients routinely receive statin prescriptions without adequate thyroid evaluation.
Chronic stress and HPA dysregulation. Cortisol is synthesized from cholesterol. When your stress response is chronically activated, your body upregulates cholesterol production to meet demand. A statin prescribed to a chronically stressed person suppresses the signal without addressing the source. The terrain continues to deteriorate.
Compromised bile production. This is the piece almost no one talks about — and it's enormous. Your liver uses cholesterol to make bile acids, which you need to digest dietary fat. When bile flow is sluggish or impaired — whether from age, gallbladder removal, or liver stress — your liver responds by producing more cholesterol to compensate for what's being lost. On a standard lipid panel, this looks like "high cholesterol." In terrain medicine, it's a bile insufficiency problem. And millions of people who've had their gallbladder removed were sent home without any support for the metabolic consequences — and many of them are now on statins.
What about statins?
I want to be thoughtful here, because statins are prescribed to reduce cardiovascular risk — and for a specific population, the research does show benefit. Men with established cardiovascular disease and high inflammatory burden do appear to benefit modestly from statin therapy.
But here's what's rarely discussed in that exam room conversation.
Statins block the mevalonate pathway — and that pathway doesn't just produce cholesterol. It also produces CoQ10, which is the essential cofactor your mitochondria need to produce energy. Every cell depends on CoQ10, but the organs with the highest demand are the heart, the liver, the kidneys, and skeletal muscle.
Let that sink in for a moment. A medication prescribed to protect the heart depletes the primary mitochondrial energy substrate the heart muscle runs on. This isn't theoretical — statin-induced cardiomyopathy is documented in the medical literature. The symptoms — fatigue, reduced exercise tolerance, shortness of breath — are frequently attributed to aging rather than to the medication.
And the benefits, when measured as absolute risk reduction rather than relative risk reduction, are often far more modest than the headlines suggest. In primary prevention populations — people without prior cardiac events — the number needed to treat to prevent a single cardiovascular event over five years ranges from 60 to over 200.
For women specifically, the evidence base is even thinner. The foundational statin trials enrolled 75–85% men with established heart disease. The data was extrapolated to women without prior cardiac events — an entirely different population — and the research specifically examining women in primary prevention has found no statistically significant reduction in total mortality.
A terrain-informed path forward
This is where things get genuinely hopeful. Because if cholesterol elevation is a response to upstream terrain problems — inflammation, insulin resistance, thyroid dysfunction, bile insufficiency, chronic stress — then addressing those upstream drivers frequently resolves the cholesterol picture without pharmacological intervention.
A terrain-informed cardiovascular assessment asks different questions. Not just "what's your LDL?" but: What is your hsCRP? Your homocysteine? Your fasting insulin? Your thyroid panel — including free T3, free T4, reverse T3, and antibodies? Your CoQ10 status? Your bile function? Your triglyceride-to-HDL ratio, which is a reliable proxy for the LDL particle pattern that actually matters?
From there, the terrain support is targeted and meaningful — CoQ10 to restore mitochondrial function, magnesium to support endothelial health and reduce vascular calcification, omega-3 fatty acids for anti-inflammatory signaling, vitamin K2 to direct calcium to bone rather than vessel walls, bile salt support for those with compromised fat metabolism, and B vitamins in methylated form to address homocysteine.
And always — always — asking why this terrain got inflamed in the first place. What is this person's stress physiology? Their sleep? Their gut integrity? Their toxic burden? Their relationship with food?
The cholesterol number on your lab report is not the story. It is one sentence in a much longer and more complex narrative. Learning to read that narrative — that's the work of terrain medicine.
If this resonates with you, I'd love to invite you to keep exploring. Our Clarity Assessment is a free place to start understanding your terrain, and if you're ready to go deeper, our team is here.
Warm Regards,
Melissa
Melissa Rose is a certified functional medicine practitioner and founder of the Rose Institute for Terrain Medicine. This content is for educational purposes and does not constitute medical advice.
